Full Length Research Paper
References
|
Al-ani M, Elemam N M, Hundt JE, Maghazachi AA (2020). Drugs for multiple sclerosis activate natural killer cells: do they protect against COVID-19 infection? Infection and Drug Resistance 13:3243-3254. |
|
|
Alanazi HH, Elasbali AM, Alanazi MK, El azab EF (2023). Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases. Molecules 28(24):8045. |
|
|
Amanya M, Ajayi CO, Natukunda B, Wasswa F, Bayiyana A, Nabatanzi R, Sande O, Agaba A (2022). Assessment of the immunomodulatory activity of Artavol® aqueous extract in Plasmodium berghei infected mice. African Journal of Pharmacy and Pharmacology 16(5):79-89. |
|
|
Babalghith AO, Al-kuraishy HM, Al-gareeb AI, De waard M, Al-hamash SM, Jean-marc S, Negm W A, Batiha GES (2022). The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 30:2003-2016. |
|
|
Behl T, Kumar K, Brisc C, Rus M, Nistor-cseppento DC, Bustea C, Aron RAC, Pantis C, Zengin G, Sehgal A (2021). Exploring the multifocal role of phytochemicals as immunomodulators. Biomedicine & Pharmacotherapy 133:110959. |
|
|
Björkström NK, Strunz B, Ljunggren HG (2022). Natural killer cells in antiviral immunity. Nature Reviews Immunology 22:112-123. |
|
|
Ghasemian M, Owlia S, Owlia MB (2016). Review of anti-inflammatory herbal medicines. Advances in Pharmacological and Pharmaceutical Sciences 2016(1):9130979. |
|
|
Iloghalu U, Miller S, Ewunkem A, Khatiwada J, Williams L (2022). Treatment Effect of Various Concentration of Plant Extracts on Murine Norovirus. Advances in Microbiology 12:242-253. |
|
|
Jantan I, Ahmad W, Bukhari SNA (2015). Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Frontiers in plant science 6:158994. |
|
|
Knoll R, Schultze JL, Schulte-schrepping J (2021). Monocytes and Macrophages in COVID-19. Frontiers in immunology 12:720109. |
|
|
Kumar M, Al khodor S (2020). Pathophysiology and treatment strategies for COVID-19. Journal of translational medicine 18:353. |
|
|
Maheshwari S, Kumar V, Bhadauria G, Mishra A (2022). Immunomodulatory potential of phytochemicals and other bioactive compounds of fruits: A review. Food Frontiers 3:221-238. |
|
|
Mollazadeh H, Cicero AF, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019). Immune modulation by curcumin: The role of interleukin-10. Critical reviews in food science and nutrition 59:89-101. |
|
|
Musoke P, Okot J, Nanfuka V, Rwamafa P, Masajjage J, Kisuule I, Nantaayi B, Ssewante N, Bongomin F (2021). A preliminary report on herbal medicine use among patients hospitalized at two-large COVID-19 treatment centers in Uganda. Risk Management and Healthcare Policy pp. 4609-4617. |
|
|
Nair A, Chattopadhyay D, Saha B (2019). Plant-derived immunomodulators. New look to phytomedicine. Elsevier. |
|
|
National Drug Authority (NDA) (2021). National Drug Authority has notified Covidex as a local herbal medicine [Online]. |
|
|
Okagu IU, Ndefo JC, Aham EC, Udenigwe C (2021). Zanthoxylum species: a review of traditional uses, phytochemistry and pharmacology in relation to cancer, infectious diseases and sickle cell anemia. Frontiers in Pharmacology 12:713090. |
|
|
Safriani N, Zakaria FR, Prangdimurti E, Verpoorte R, Yuliana ND (2022). Using metabolomics to discover the immunomodulator activity of food plants. Heliyon 8(5). |
|
|
Samec M, Liskova A, Koklesova L, Samuel SM, Murin R, Zubor P, Bujnak J, Kwon TK, Büsselberg D, Prosecky R (2020). The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis. Journal of Cancer Research and Clinical Oncology 146:3137-3154. |
|
|
Saraiva M, Vieira P, O'garra A (2019). Biology and therapeutic potential of interleukin-10. Journal of Experimental Medicine 217:e20190418. |
|
|
Shao J, Zeng D, Tian S, Liu G, Fu J (2020). Identification of the natural product berberine as an antiviral drug. AMB Express 10:1-11. |
|
|
Singh R, Goel S, Bourgeade P, Aleya L, Tewari D (2021). Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environmental Science and Pollution Research pp. 1-27. |
|
|
Tucureanu MM, Rebleanu D, Constantinescu CA, Deleanu M, Voicu G, Butoi E, Calin M, Manduteanu I (2018). Lipopolysaccharide-induced inflammation in monocytes/macrophages is blocked by liposomal delivery of Gi-protein inhibitor. International Journal of nanomedicine pp. 63-76. |
|
|
Valipour M, Zakeri khatir Z, Abdollahi E, Ayati A (2023). Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017-2023). ACS Pharmacology and Translational Science 7:48-71. |
|
|
Varghese FS, Van Woudenbergh E, Overheul GJ, Eleveld MJ, Kurver L, Van heerbeek N, Van laarhoven A, Miesen P, Den hartog G, De jonge M I (2021). Berberine and obatoclax inhibit SARS-Cov-2 replication in primary human nasal epithelial cells in vitro. Viruses 13:282. |
|
|
Wong RS (2021). Inflammation in COVID-19: from pathogenesis to treatment. International journal of clinical and experimental pathology 14:831. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
